Volume 71 of Issue 2 | CA: a cancer journal for clinicians
Authors: Cheng ML, Pectasides E, Hanna GJ, Parsons HA, Choudhury AD, Oxnard GR
The application of genomic profiling assays using plasma circulating tumor DNA (ctDNA) is rapidly evolving in the management of patients with advanced solid tumors. Diverse plasma ctDNA technologies in both commercial and academic laboratories are in routine or emerging use. The increasing integration of such testing to inform treatment decision making by oncology clinicians has complexities and challenges but holds significant potential to substantially improve patient outcomes. In this review, the authors discuss the current role of plasma ctDNA assays in oncology care and provide an overview of ongoing research that may inform real-world clinical applications in the near future.
View on PubMed
TO REMOVE
Authors: Stage TB, Hu S, Sparreboom A, Kroetz DL
TO REMOVE
Authors: Moody SY
TO REMOVE
Authors: Ganson KT, Tsai AC, Weiser SD, Benabou SE, Nagata JM
Nature medicine
Authors: Gu W, Deng X, Lee M, Sucu YD, Arevalo S, Stryke D, Federman S, Gopez A, Reyes K, Zorn K, Sample H, Yu G, Ishpuniani G, Briggs B, Chow ED, Berger A, Wilson MR, Wang C, Hsu E, Miller S, DeRisi JL, Chiu CY
Nutrients
Authors: Tu MY, Han KY, Chang GR, Lai GD, Chang KY, Chen CF, Lai JC, Lai CY, Chen HL, Chen CM
Viruses
Authors: Fujinaga K, Cary DC
Intensive care medicine
Authors: Vignon P, Evrard B, Asfar P, Busana M, Calfee CS, Coppola S, Demiselle J, Geri G, Jozwiak M, Martin GS, Gattinoni L, Chiumello D
Journal of medical Internet research
Authors: Sharma AE, Mann Z, Cherian R, Del Rosario JB, Yang J, Sarkar U
Nature communications
Authors: Hara-Chikuma M, Tanaka M, Verkman AS, Yasui M
